Program overview
Context
Indication: Solid Tumor
Mechanism: Unknown
Modality: Unknown
Sponsor: Daehwa Pharmaceutical Co., .
Registry Stop Signal
Paclitaxel
Paclitaxel is flagged as registry stop signal because public records show a registry stop signal, public results not found after completion. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 5/5
Timeline: 1/5
Recruitment burden: 1/5
Results availability: 3/5
Program risk: 5/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT02890511 | https://clinicaltrials.gov/study/NCT02789657 | https://clinicaltrials.gov/study/NCT00622466 | https://clinicaltrials.gov/study/NCT02392377
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02890511 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | None |
| NCT02789657 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | strict_eligibility_signal |
| NCT00622466 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | strict_eligibility_signal |
| NCT02392377 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | rare_population_signal |